Prostate cancer: open trials in Estonia

3 open trials have a site in Estonia. Registry data; only the trial team decides who can take part.

NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Sihtasutus Parnu Haigla, Parnu Linn · East Tallinn Central Hospital, Tallinn · North Estonia Medical Centre Foundation, Tallinn · Tartu University Hospital, Tartu Linn
Registry updated 2026-10-20
2024-517854-91-00
Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy
Trial Treatment · Phase 3 · Pirkanmaan hyvinvointialue
Tartu University Hospital, Tartu Linn
Registry updated 2026-10-08
2025-521551-23-01
Sequential Chemotherapy regimen with vinorelbine and cisplatin plus PET-guided stereotactic ablative radiotherapy (SABR) for castration- and taxane-resistant Prostate cancer (ChemSABR Prostate)
Trial Treatment · Phase 1/2 · Tartu University Hospital
Tartu University Hospital, Tartu Linn
Registry updated 2025-06-26

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)